NorthWest Biotherapeutics Inc (NWBO)

[VikingInvest]

I will agree to the extent that the initial deal will have exclusivity for certain indications, but nor for all solid tumor cancers. The rest could be up for grabs. The value of upfront cash and milestone payments will be minimized if they don’t do a limited exclusive deal and will result in just the sales from using DCVax-L in combination. It’s also not conducive for a BP to sponsor trials that other BP’s can use later on. JMHO

I am coming at this from the business side and I admit that my idea of partnership is to maximize the value for NWBO. I don’t know what effect an exclusive deal will have on patients, but I do think that an exclusive deal will provide a much faster set of combination trials and faster approval for other indications.